Liver TCRγδ+ CD3+ CD4- CD8- T cells contribute to murine hepatitis virus strain 3-induced hepatic injury through a TNF-α-dependent pathway

Molecular Immunology

Volumn 52, Issue 3-4, 2012, Pages 229-236

  Lu, Yulei ^a   Wang, Xiaojing ^a   Yan, Weiming ^a   Wang, Hongwu ^a   Wang, Ming ^a   Wu, Di ^a   Zhu, Lin ^a   Luo, Xiaoping ^a   Ning, Qin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C3H HeJ; Double negative T cells; Murine hepatitis virus strain 3; TCR +; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA DELTA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD3+ CD4- CD8- T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CELL CONTACT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOUBLE NEGATIVE T LYMPHOCYTE; HISTOPATHOLOGY; LIVER CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; MURINE HEPATITIS CORONAVIRUS; MURINE HEPATITIS VIRUS 3; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; VIRUS HEPATITIS;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CELLS, CULTURED; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MURINE HEPATITIS VIRUS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 3; MUS;

EID: 84862732110     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.05.017     Document Type: Article

References (25)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Reviews. Immunology 2003, 3:745-756.
2. Antonelli L.R., Dutra W.O., Oliveira R.R., Torres K.C., Guimaraes L.H., Bacellar O., Gollob K.J. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infection and Immunity 2006, 74:6317-6323.
3. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annual Review of Immunology 2007, 25:297-336.
4. Cowley S.C., Meierovics A.I., Frelinger J.A., Iwakura Y., Elkins K.L. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. Journal of Immunology 2010, 184:5791-5801.
5. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nature Reviews. Immunology 2010, 10:479-489.
6. Fischer K., Voelkl S., Przybylski G.K., Schmidt C.A., Andreesen R., Mackensen A. Isolation and characterization of human antigen-specific TCR alpha beta(+) CD4(-)CD8(-) double negative regulatory T cells. Blood 2005, 106:3306.
7. Hammerich L., Heymann F., Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clinical and Developmental Immunology 2011.
8. Ichiki Y., He X.S., Shimoda S., Ishibashi H., Keeffe E.B., Rossaro L., Gershwin M.E. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmunity Reviews 2005, 4:82-95.
9. Jeng J.E., Tsai J.F., Chuang L.Y., Ho M.S., Lin Z.Y., Hsieh M.Y., Chen S.C., Chuang W.L., Wang L.Y., Yu M.L., Dai C.Y., Chang J.G. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 2007, 9:987-992.
10. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994, 265:528-530.
11. Kakimi K., Lane T.E., Wieland S., Asensio V.C., Campbell I.L., Chisari F.V., Guidotti L.G. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. Journal of Experimental Medicine 2001, 194:1755-1766.
12. Kanayama K., Morise K., Nagura H. Immunohistochemical study of T cell receptor gamma delta cells in chronic liver disease. American Journal of Gastroenterology 1992, 87:1018-1022.
13. Liu M., Mendicino M., Ning Q., Ghanekar A., He W., McGilvray I., Shalev I., Pivato D., Clark D.A., Phillips M.J., Levy G.A. Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. Journal of Immunology 2006, 176:7028-7038.
14. Manigold T., Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infectious Diseases 2007, 7:804-813.
15. Ning Q., Brown D., Parodo J., Cattral M., Gorczynski R., Cole E., Fung L., Ding J.W., Liu M.F., Rotstein O., Phillips M.J., Levy G. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. Journal of Immunology 1998, 160:3487-3493.
16. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. Journal of Hepatology 1998, 28:84-90.
17. Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Reviews. Immunology 2005, 5:215-229.
18. Schattenberg J.M., Schuchmann M., Galle P.R. Cell death and hepatocarcinogenesis: dysregulation of apoptosis signaling pathways. Journal of Gastroenterology and Hepatology 2011, 26(Suppl. 1):213-219.
19. Seki S., Abo T., Masuda T., Ohteki T., Kanno A., Takeda K., Rikiishi H., Nagura H., Kumagai K. Identification of activated T cell receptor gamma delta lymphocytes in the liver of tumor-bearing hosts. Journal of Clinical Investigation 1990, 86:409-415.
20. Shinohara K., Ikarashi Y., Maruoka H., Miyata M., Sugimura T., Terada M., Wakasugi H. Functional and phenotypical characteristics of hepatic NK-like T cells in NK1.1-positive and -negative mouse strains. European Journal of Immunology 1999, 29:1871-1878.
21. Thomson C.W., Lee B.P.L., Zhang L. Double-negative regulatory T cells - Non-conventional regulators. Immunologic Research 2006, 35:163-177.
22. Wondimu Z., Santodomingo-Garzon T., Le T., Swain M.G. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. American Journal of Pathology 2010, 177:2334-2346.
23. Zhang J.Y., Zhang Z., Lin F., Zou Z.S., Xu R.N., Jin L., Fu J.L., Shi F., Shi M., Wang H.F., Wang F.S. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic Hepatitis B. Hepatology 2010, 51:81-91.
24. Zhang Z.X., Yang L., Young K.J., DuTemple B., Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nature Medicine 2000, 6:782-789.
25. Zou Y., Chen T., Han M., Wang H., Yan W., Song G., Wu Z., Wang X., Zhu C., Luo X., Ning Q. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. Journal of Immunology 2010, 184:466-475.